Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | BS59L | — |
only diluent; only diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old male patient who received Hib (Hiberix) (batch number BS59L, expiry date 02-AUG-2026) for prophylaxis. On 02-OCT-2025, the patient received the 1st dose of Hiberix. On 02-OCT-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: only diluent) and inappropriate dose of vaccine administered (Verbatim: only diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 11-NOV-2025 Medical assistant called regarding the Hiberix vaccine two patients got the vaccine, but one was not correctly administered and did not know which patient got the good one. The complete vaccine administered 21-OCT-2025. The reporter asked was it safe to readminister it to both patients. The reporter did not consent to follow-up. This case was linked with case US2025146502 reported by the same reporter, for different patient.; Sender's Comments: US-GSK-US2025146502:Same Reporter